Literature DB >> 11005785

Expression of epidermal growth factor and transforming growth factor alpha in interfacial membranes retrieved at revision total hip arthroplasty.

J W Xu1, J Ma, T F Li, E Waris, A Alberty, S Santavirta, Y T Konttinen.   

Abstract

BACKGROUND: The interfacial membrane between bone and implant has been shown to be a key tissue in the process of aseptic loosening of total hip arthroplasty. The cells within the interfacial membrane produce numerous inflammatory mediators which, through complex mechanisms, cause periprosthetic osteolysis and aseptic loosening. Both epidermal growth factor (EGF) and transforming growth factor alpha (TGFalpha) have similar biological functions. They have been found to stimulate bone resorption.
OBJECTIVE: To investigate the presence, cellular localisation, and extent of expression of EGF and TGFalpha in interfacial membrane retrieved from revision total hip arthroplasty and compare it with that in synovial membrane from primary total hip arthroplasty.
METHODS: Ten interfacial membranes and 10 synovial membranes were stained with avidin-biotin-peroxidase complex for EGF and TGFalpha. The staining process was done using the Lab Vision Autostainer. The results were measured by a semiautomatic VIDAS image analysis system.
RESULTS: Immunoreactivity for both EGF and TGFalpha was found in the endothelial cells of blood vessels, macrophages, and fibroblasts, both in interfacial membranes and synovial membranes. However, the number of EGF (980 (370)) and TGFalpha (1070 (360)) positive cells per mm(2) was greater in interfacial membranes than in the synovial membranes (220 (200), 270 (100); p<0.01).
CONCLUSION: It is suggested that owing to their increased expression in interfacial membrane, EGF and TGFalpha may have an important pathogenetic role in stimulating periprosthetic bone resorption in aseptic loosening of total hip arthroplasty.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005785      PMCID: PMC1753009          DOI: 10.1136/ard.59.10.822

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  27 in total

1.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

Review 2.  The physiology of transforming growth factor-alpha.

Authors:  R Derynck
Journal:  Adv Cancer Res       Date:  1992       Impact factor: 6.242

3.  Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.

Authors:  R Ebner; R Derynck
Journal:  Cell Regul       Date:  1991-08

4.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

5.  Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty.

Authors:  Y T Konttinen; V Waris; J W Xu; W A Jiranek; T Sorsa; I Virtanen; S Santavirta
Journal:  J Rheumatol       Date:  1997-04       Impact factor: 4.666

6.  Interleukin-11 (IL-11) in aseptic loosening of total hip replacement (THR).

Authors:  J W Xu; T F Li; G Partsch; A Ceponis; S Santavirta; Y T Konttinen
Journal:  Scand J Rheumatol       Date:  1998       Impact factor: 3.641

7.  Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty.

Authors:  A S Shanbhag; J J Jacobs; J Black; J O Galante; T T Glant
Journal:  J Arthroplasty       Date:  1995-08       Impact factor: 4.757

8.  Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria.

Authors:  A H Tashjian; E F Voelkel; M Lazzaro; F R Singer; A B Roberts; R Derynck; M E Winkler; L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures.

Authors:  N Takahashi; B R MacDonald; J Hon; M E Winkler; R Derynck; G R Mundy; G D Roodman
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

10.  Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro.

Authors:  K J Ibbotson; J Harrod; M Gowen; S D'Souza; D D Smith; M E Winkler; R Derynck; G R Mundy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

View more
  2 in total

Review 1.  The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses.

Authors:  Peter A Revell
Journal:  J R Soc Interface       Date:  2008-11-06       Impact factor: 4.118

2.  Pathological analysis of periprosthetic soft tissue and modes of failure in revision total joint arthroplasty patients.

Authors:  Patrick Bettiol; Alec Egan; Cameron Cox; Eric Wait; George Brindley
Journal:  SAGE Open Med       Date:  2021-09-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.